All stock lists
Copart Inc (NASDAQ:CPRT)
US · Delayed Price · Currency is USD
Industrials · Specialty Business Services
29.15+0.15 (+0.52%)
Insider Score
––Not scored
CPRT Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
CPRT Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jul 31, 2026 | Apr 30, 2026 | Jan 31, 2026 | Oct 31, 2025 | Jul 31, 2025 | Apr 30, 2025 |
| Revenue | 1.15 B | 1.24 B | 1.12 B | 1.16 B | 1.13 B | 1.21 B |
| Revenue Growth (YoY) | 2.43 % | 2.09 % | -3.58 % | 0.72 % | 5.25 % | 7.49 % |
| Cost of Revenue | 670.99 M | 664.47 M | 628.86 M | 618.03 M | 615.38 M | 659.45 M |
| Gross Profit | 481.45 M | 572.60 M | 492.81 M | 537.00 M | 509.72 M | 552.27 M |
| SG&A Expense | 155.86 M | 93.74 M | 89.39 M | 92.27 M | 83.90 M | 100.72 M |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 112.55 M | 108.32 M | 104.10 M | 106.30 M | 97.13 M | 100.72 M |
| Operating Income | 368.90 M | 464.28 M | 388.71 M | 430.69 M | 412.59 M | 451.55 M |
| Pretax Income | 404.71 M | 502.09 M | 441.05 M | 487.12 M | 478.41 M | 502.80 M |
| Tax Provision | 77.88 M | 100.70 M | 91.08 M | 84.91 M | 83.10 M | 97.47 M |
| Net Income | 327.42 M | 402.40 M | 350.73 M | 403.71 M | 396.35 M | 406.61 M |
| EPS (Basic) | 0.35 | 0.43 | 0.36 | 0.42 | 0.41 | 0.42 |
| EPS (Diluted) | 0.35 | 0.43 | 0.36 | 0.41 | 0.41 | 0.42 |
| Shares Outstanding | 949.64 M | 957.28 M | 967.43 M | 967.65 M | 967.10 M | 966.23 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
